Results 331 to 340 of about 195,889 (397)

Assessing the developmental effects of fentanyl and impacts on lipidomic profiling using neural stem cell models. [PDF]

Exp Biol Med (Maywood)
Wang C, Sun J, Donakonda R, Beger R, Latham LE, Wu L, Liu S, Hanig JP, Liu F.   +8 more
europepmc   +1 more source

Precision Adjuvant Strategies in Vaccine Development for Substance Use Disorders: Variability and Mechanistic Insights. [PDF]

Pharmaceutics
Bian Y, Ci Q, Luo XM, Zhang C.
europepmc   +1 more source

Esketamine versus fentanyl as adjuncts to hepatic hilar nerve block for ambulatory percutaneous liver tumor ablation focusing on respiratory safety: protocol for a randomized controlled trial. [PDF]

Front Pharmacol
Wang X, Yan L, Cai J, Wei J, Zhang Z, Yang B.   +5 more
europepmc   +1 more source

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research

Addiction, Volume 120, Issue 11, Page 2177-2178, November 2025.
James S. H. Wong, Anthony Lau, Pouya Azar   +2 more
wiley   +1 more source

Remifentanil Versus Fentanyl in Critically Ill Patients Requiring Mechanical Ventilation: A Single-Center Retrospective Cohort Study. [PDF]

Cureus
Hasegawa S, Okano H, Jujo S, Okamoto H.
europepmc   +1 more source

From fairytale to clinical practice: A response to commentaries

Addiction, Volume 120, Issue 11, Page 2179-2180, November 2025.
Mariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, Nicola Metrebian, Nicola Kalk, Arne Kristian Skulberg, Paul Dietze, Martin Smith, John Strang   +8 more
wiley   +1 more source

Membrane Permeability Drives the Extreme Potency of Fentanyl but not Isotonitazene

Clayton J, Farmer G, Glenn J, Mistry S, Lane JR, Shi L, Stavitskaya L, Canals M, Shen J.   +8 more
europepmc   +1 more source

Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths.

JAMA Health Forum
Jurecka C, Adams J, Padmanabhan P, Glanz J, Christine P, Guan X, Kline D, Binswanger I, Barocas J.   +8 more
europepmc   +1 more source

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting.

JAMA Netw Open
Waters RC, Hoog J, Bell C, Toland P, Valley J, Hurtado L, Kallsen MA, Johnson T, Gerard A, Fockele CE, Klein JW.   +10 more
europepmc   +1 more source